罗欣药业集团股份有限公司关于控股股东部分股份解除质押及质押的公告

Core Viewpoint - The announcement details the release and pledge of shares by the controlling shareholder of Luoxin Pharmaceutical Group Co., Ltd., indicating no significant impact on the company's operations or governance [1]. Summary by Sections Share Pledge Release - The controlling shareholder, Shandong Luoxin Holdings Co., Ltd., has notified the company about the release and pledge of part of its shares [1]. - The total share capital is calculated based on 1,087,588,486 shares [5]. Share Pledge Situation - As of the announcement date, the controlling shareholder and its concerted parties, including Karamay Juezhi Equity Investment Management Partnership and Giant Star Global (HK) Limited, have pledged shares [1]. - The pledged shares are not related to significant asset restructuring or performance compensation obligations [1]. - There are no non-operating fund occupations or illegal guarantees that harm the interests of the listed company [1]. Impact on Company - The share pledge does not affect the company's production, governance, or performance compensation obligations [1]. - The pledged shares are not intended to meet the operational needs of the listed company [5]. - There are no pledged shares due to expire within the next year [5].